Tumor Suppressor Gene Alterations in Bladder Carcinoma
- 1 April 1995
- journal article
- Published by Elsevier in Surgical Oncology Clinics of North America
- Vol. 4 (2), 231-240
- https://doi.org/10.1016/s1055-3207(18)30450-2
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- p53 mutations in human bladder cancer: Genotypic versus phenotypic patternsInternational Journal of Cancer, 1994
- Over‐expression of p53 nuclear oncoprotein in transitional‐cell bladder cancer and its prognostic valueInternational Journal of Cancer, 1993
- Molecular Genetic Alterations of Chromosome 17 and p53 Nuclear Overexpression in Human Bladder CancerDiagnostic Molecular Pathology, 1993
- Altered Expression of the Retinoblastoma Gene Product: Prognostic Indicator in Bladder CancerJNCI Journal of the National Cancer Institute, 1992
- Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene productNature, 1991
- The retinoblastoma protein copurifies with E2F-I, an E1A-regulated inhibitor of the transcription factor E2FCell, 1991
- The p53 tumour suppressor geneNature, 1991
- Oncogenes and Tumor-Suppressing GenesNew England Journal of Medicine, 1988
- Mutation and Cancer: Statistical Study of RetinoblastomaProceedings of the National Academy of Sciences, 1971
- Suppression of Malignancy by Cell FusionNature, 1969